News Archive
Exercise of Commercial Options
Eden Research plc, a leading UK agrochemical development company, is pleased to announce that its licensee, Cheminova AS, has exercised its option, under an agreement dated 14 May 2007, to take a further seventeen countries as part of the rollout programme for Eden’s Terpene based Botrytis treatment.
Under the terms of the agreement, Cheminova will be responsible for local field trials and relevant national registrations.
Tim Griffiths, the Chief Executive of Eden Research plc, said:-
“Cheminova has decided to exercise its option to extend the territories for its rights to commercialise 3AEY in most of Europe and much of the Americas and the CIS. This is a significant milestone in the rollout and development of 3AEY.”
For further information:
Tim Griffiths, Chief Executive
Eden Research plc
Tel: 01993 868844
Matthew Robinson
FinnCap
Tel: 020 7600 1658
ABOUT EDEN RESEARCH PLC
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.
For further information please visit www.edenresearch.com.
ABOUT CHEMINOVA
Cheminova is a manufacturer of fine chemicals, with its main business area within plant protection products. Cheminova has developed a wide range of plant protection products by in-house process and formulation development, and markets its products globally through subsidiaries in 16 key countries and through distribution partners in most other countries.
The annual turnover is approximately 4 billion Danish Kroner (DKK). Cheminova employs 800 people in Denmark and 750 abroad. Cheminova is 100% owned by Auriga Industries A/S, a publicly traded company on the Copenhagen Stock Exchange.
For further information, please visit www.cheminova.com.